|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/2875 | (2013.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/244 | (2013.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 21/04 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3143047 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15724070.6 |
| Date of filing the European patent application | 2015-05-15 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/053602 |
| Date | 2015-05-15 |
| (87) | Number | WO 2015/173782 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461994427 P | 2014-05-16 | US | |
| 201462093734 P | 2014-12-18 | US | |
| 201462095181 P | 2014-12-22 | US |
| (72) |
BLAKE-HASKINS, Angela , US
MARSHALL, Tristan , US
O'BERRY, Kristen , US
PERKINS, Melissa D. , US
|
| (73) |
GlaxoSmithKline Intellectual Property
Management Limited ,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
GlaxoSmithKline Intellectual Property Limited , 980 Great West Road, Brentford, Middlesex TW8 9GS, GB |
| (54) | BELIMUMAB FORMULATION |
| BELIMUMAB FORMULATION |